Agnese Biagini

BRAFV600E Mutation and Outcome of Patients with Papillary Thyroid Carcinoma: A 15-Year Median Follow-Up Study

Rossella Elisei, Clara Ugolini, David Viola et al. · The Journal of Clinical Endocrinology & Metabolism · 2008 · 527 citations

Medicine, Molecular Genetics, Oncology +16

The<i>BRAF</i>V600E Mutation Is an Independent, Poor Prognostic Factor for the Outcome of Patients with Low-Risk Intrathyroid Papillary Thyroid Carcinoma: Single-Institution Results from a Large Cohort Study

Rossella Elisei, David Viola, Liborio Torregrossa et al. · The Journal of Clinical Endocrinology & Metabolism · 2012 · 236 citations · Full text

Medicine, Molecular Genetics, Oncology +12

RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC)

Cristina Romei, B Cosci, Giulia Renzini et al. · Clinical Endocrinology · 2010 · 128 citations · Full text

Medicine, Genetics, Molecular Genetics +17

Surgical Treatment of Low- and Intermediate-Risk Papillary Thyroid Cancer with Minimally Invasive Video-Assisted Thyroidectomy

Paolo Miccoli, Aldo Pinchera, Gabriele Materazzi et al. · The Journal of Clinical Endocrinology & Metabolism · 2009 · 96 citations · Full text

Medicine, Oncology, Surgery +16

Prognostic Factors in Papillary Microcarcinoma with Emphasis on Histologic Subtyping: A Clinicopathologic Study of 148 Cases

Ronald Ghossein, Ian Ganly, Agnese Biagini et al. · Thyroid · 2013 · 68 citations

Medicine, Oncology, Pathology +17